(Q35036911)

English

Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI. (English)

1 reference

Europe PubMed Central

5 August 2017

Hypericum perforatum

0 references

author name string

Stella Bitran

1

1 reference

Europe PubMed Central

5 August 2017

Amy H Farabaugh

2

1 reference

Europe PubMed Central

5 August 2017

Victoria E Ameral

3

1 reference

Europe PubMed Central

5 August 2017

Rachel A LaRocca

4

1 reference

Europe PubMed Central

5 August 2017

Alisabet J Clain

5

1 reference

Europe PubMed Central

5 August 2017

Maurizio Fava

6

1 reference

Europe PubMed Central

5 August 2017

David Mischoulon

7

1 reference

Europe PubMed Central

5 August 2017

publication date

1 July 2011

1 reference

Europe PubMed Central

5 August 2017

International Clinical Psychopharmacology

1 reference

Europe PubMed Central

5 August 2017

26

1 reference

Europe PubMed Central

5 August 2017

206-212

1 reference

Europe PubMed Central

5 August 2017

4

1 reference

Europe PubMed Central

5 August 2017

Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Accelerating response to antidepressant treatment in depression: a review and clinical suggestions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

St John's wort for major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

A rating scale for depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Duloxetine in treatment of anxiety symptoms associated with depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Why patients use alternative medicine: results of a national study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Early treatment response in anxious outpatients treated with diazepam.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

8 July 2018

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Early symptom change prediction of remission in depression treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Predictors of relapse in a prospective study of fluoxetine treatment of major depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Early response and 8-week treatment outcome in GAD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111899

25 October 2018

Anxiety disorders in major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of Onset of Antidepressant Response With Fluoxetine Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early improvement as a predictor of response to amitriptyline and nortriptyline: a comparison of 2 patient samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of true drug response to antidepressants. Use of pattern analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of improvement under antidepressant treatment: a survival-analytical approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early nonresponse to fluoxetine as a predictor of poor 8-week outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Baseline severity of depression predicts antidepressant drug response relative to escitalopram

1 reference

https://pubmed.ncbi.nlm.nih.gov/21278577

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/YIC.0B013E328343BA08

1 reference

Europe PubMed Central

5 August 2017

release_arvlavypn5hu5nyhhthy3xh6je

1 reference

https://api.fatcat.wiki/v0/release/arvlavypn5hu5nyhhthy3xh6je

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35036911&oldid=1844592353"